The number of geriatric patients on dialysis is increasing. This is due to demographic factors, a wider acceptance of elderly patients on dialysis, and an earlier start of dialysis in this patient group. Recent studies have questioned the effect of dialysis on quality of life in elderly patients with severe comorbidity and showed limited survival in this specific patient group. Therefore, the decision whether or not to start dialysis may be a difficult one for both the clinician and patient. Risk scores can be of help in facilitating shared decision making, but not as a tool to withhold dialysis. However, in the elderly patient with severe comorbidity, conservative care can sometimes be a reasonable alternative to dialysis. In the process of shared decision making, a balance should be pursued between life expectancy and quality of life. If the decision to initiate dialysis is taken, choices have to be made regarding dialysis modality and treatment prescription. If adequate support is provided, assisted peritoneal dialysis can be an acceptable alternative to hemodialysis. Care for the elderly with end-stage renal disease should be undertaken by a multidisciplinary team with special dedication to a multidimensional approach in this population.

Keywords:
Geriatric patients, End-stage renal disease, Renal replacement therapy
1.
Kramer A, Stel V, Zoccali C, Heaf J, Ansell D, Grönhagen-Riska C, Leivestad T, Simpson K, Pálsson R, Postorino M, Jager K, ERA-EDTA Registry: An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol Dial Transplant 2009;24:3557–3566.
2.
DOPPS Canaud B, Long T, Tentori F, Akiba T, Karaboyas A, Gillespie B, Akizawa T, Pisoni RL, Bommer J, Port FK: Clinical practices and outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2011;6:1651–1662.
3.
Kurella M, Covinsky KE, Collins AJ, Chertow GM: Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 2007;146:177–183.
4.
Couchoud C, Labeeuw M, Moranne O, Allot V, Esnault V, Frimat L, Stengel B: French Renal Epidemiology and Information Network (REIN) registry: a clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant 2009;24:1553–1561.
5.
Jassal SV, Watson D: Dialysis in late life: benefit or burden. Clin J Am Soc Nephrol 2009;4:2008–2012.
6.
United States Renal Data System 2010: Patient characteristics. Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Am J Kidney Dis 2011;57(suppl 1):e267–e276.
7.
Chandna SM, Schulz J, Lawrence C, et al: Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ 1999;318:217–223.
8.
Cohen LM, Ruthazer R, Moss AH, Germain MJ: Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin J Am Soc Nephrol 2010;5:72–79.
9.
Kurella Tamura M, O’Hare AM, McCulloch CE, Johansen KL: Signs and symptoms associated with earlier dialysis initiation in nursing home residents. Am J Kidney Dis 2010;56:1117–1126.
10.
Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA, et al: A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010;363:606–619.
11.
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146–M156.
12.
Johansen KL, Chertow GM, Jin C, Kutner NG: Significance of frailty among dialysis patients. J Am Soc Nephrol 2007;18:2960–2967.
13.
Kurella M, Chertow GM, Luan J, Yaffe K: Cognitive impairment in chronic kidney disease. J Am Geriatr Soc 2004;52:1863–1869.
14.
Jassal SV, Chiu E, Hladunewich M: Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med 2009;361:1612–1613.
15.
Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE: Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009;361:1539–1547.
16.
Murtagh FE, Addington-Hall JM, Higginson IJ: End-stage renal disease: a new trajectory of functional decline in the last year of life. J Am Geriatr Soc 2011;59:304–308.
17.
Fassett RG, Robertson IK, Mace R, Youl L, Challenor S, Bull R: Palliative care in end-stage kidney disease. Nephrology (Carlton) 2011;16:4–12.
18.
Kurella Tamura M, Cohen LM: Should there be an expanded role for palliative care in end-stage renal disease? Curr Opin Nephrol Hypertens 2010;19:556–560.
19.
Burns A, Davenport A: Maximum conservative management for patients with chronic kidney disease stage 5. Hemodial Int 2010;14:S32–S37.
20.
Kurella Tamura M: Incidence, management, and outcomes of end-stage renal disease in the elderly. Curr Opin Nephrol Hypertens 2009;18:252–257.
21.
Joly D, Anglicheau D, Alberti C, et al: Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol 2003;14:1012–1021.
22.
Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K: Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant 2011;26:1608–1614.
23.
Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 2007;22:1955–1962.
24.
Carson RC, Juszczak M, Davenport A, Burns A: Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 2009;4:1611–1619.
25.
Burns A, Davenport A: Functional status of elderly adults receiving dialysis. N Engl J Med 2010;362:468–469.
26.
Galla JH: Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. J Am Soc Nephrol 2000;11:1340–1342.
27.
Moss AH: Revised dialysis clinical practice guideline promotes more informed decision-making. Clin J Am Soc Nephrol 2010;5:2380–2383.
28.
Tislér A, Akócsi K, Hárshegyi I, Varga G, Ferenczi S, Grosz M, Kulcsár I, Löcsey L, Sámik J, Solt I, Szegedi J, Tóth E, Wágner G, Kiss I: Comparison of dialysis and clinical characteristics of patients with frequent and occasional hemodialysis associated hypotension. Kidney Blood Press Res 2002;25:97–102.
29.
Stefanidis I, Bach R, Mertens PR, Liakopoulos V, Liapi G, Mann H, Heintz B: Influence of hemodialysis on the mean blood flow velocity in the middle cerebral artery. Clin Nephrol 2005;64:129–137.
30.
Cornelis T, Kotanko P, Goffin E, Kooman JP, van der Sande FM, Chan CT: May intensive hemodialysis be an option to prevent loss of functionality in the elderly ESRD patient? Semin Dial, in press.
31.
Jassal SV, Devins GM, Chan CT, Bozanovic R, Rourke S: Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: a longitudinal pilot study. Kidney Int 2006;70:956–962.
32.
Lacson E Jr, Wong W, Lester K, et al: Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program. Clin J Am Soc Nephrol 2010;5:220–226.
33.
Derrett S, Darmody M, Williams S, Rutherford M, Schollum J, Walker R: Older peoples’ satisfaction with home-based dialysis. Nephrology 2010;15:464–470.
34.
Ocak G, Halbesma N, le Cessie S, Hoogeveen EK, van Dijk S, Kooman J, Dekker FW, Krediet RT, Boeschoten EW, Verduijn M: Haemodialysis catheters increase mortality as compared to arteriovenous accesses especially in elderly patients. Nephrol Dial Transplant 2011;26:2611–2617.
35.
NKF-KDOQI clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 2006;48(suppl 1):S2–S90.
36.
Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D, Kooman J, Martin-Malo A, Pedrini L, Pizzarelli F, Tattersall J, Vennegoor M, Wanner C, ter Wee P, Vanholder R: EBPG on vascular access. Nephrol Dial Transplant 2007;22(suppl 2):ii88–ii117.
37.
Buemi M, Lacquaniti A, Bolignano D, Donato V, Fazio MR, Campo S, Coppolino G, Sturiale A: Dialysis and the elderly: an underestimated problem. Kidney Blood Press Rev 2008;31:330–336.
38.
van de Luijtgaarden MW, Noordzij M, Stel VS, Ravani P, Jarraya F, Collart F, Schön S, Leivestad T, Puttinger H, Wanner C, Jager KJ: Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe. Nephrol Dial Transplant 2011;26:2940–2947.
39.
Stack AG: Determinants of modality selection among incident US dialysis patients: results from a national study. J Am Soc Nephrol 2002;13:1279–1287.
40.
Jager KJ, Korevaar JC, Dekker FW, Krediet RT, Boeschoten EW, Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group: The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis 2004;43:891–899.
41.
Povlsen JV, Ivarsen P: Assisted automated peritoneal dialysis for the functionally dependent and elderly patient. Perit Dial Int 2005;25(suppl 3):S60–S63.
42.
Vonesh EF, Snyder JJ, Foley RN, Collins AJ: The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004;66:2389–2401.
43.
Jassal SV, Watson D: Doc, don’t procrastinate... rehabilitate, palliate, and advocate. Am J Kidney Dis 2010;55:209–212.
44.
Heldal K, Hartmann A, Grootendorst DC, de Jager DJ, Leivestad T, Foss A, Midtvedt K: Benefit of kidney transplantation beyond 70 years of age. Nephrol Dial Transplant 2010;25:1680–1687.
45.
de Jager DJ, Voormolen N, Krediet RT, Dekker FW, Boeschoten EW, Grootendorst DC, NECOSAD Study Group: Association between time of referral and survival in the first year of dialysis in diabetics and the elderly. Nephrol Dial Transplant 2011;26:652–658.
46.
Levin A: Consequences of late referral on patient outcomes. Nephrol Dial Transplant 2000;15(suppl 3):8–13.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.